title: Primary malignant fibrous histiocytoma   of the pancreas: benefit of the multidisciplinary approach.
abstract: Primary malignant fibrous histiocytoma (MFH) is an exceedingly rare tumour of the pancreas with a high recurrence rate and a poor prognosis. Only 11 cases have been reported in the past in the English literature. In this report, the authors present the case of a 45-year-old man who was first operated on for a primary MFH of the pancreas. Eleven months after the surgery, he was diagnosed with a tumoural recurrence presenting as hepatic and pulmonary metastasis. The patient underwent a multidisciplinary treatment of chemotherapy, percutaneous radiofrequency ablation, and a right hepatectomy combined with intraoperative radiofrequency ablation. Under multidisciplinary treatment, the patient fully recovered. He remains disease-free 3 years after his first surgery and 25 months after the recurrence. We report a case of a primary MFH of the pancreas treated by using a multidisciplinary approach resulting in an above average survival rate. Although further cases and longer follow-up periods are necessary to conclude about the role of multidisciplinary treatment in the long-term prognosis of primary MFH of the pancreas, we believe that multidisciplinary treatment could improve the survival rates of other patients.
authors.affiliation: Bergonie Cancer Institute, 229 cours de l'Argonne, Bordeaux 33000, France. julienjarry@hotmail.com
authors.forename: Julien
authors.initials: J
authors.lastname: Jarry
authors.forename: Genevieve
authors.initials: G
authors.lastname: Belleannee
authors.forename: Christophe
authors.initials: C
authors.lastname: Laurent
authors.forename: Jean Michel
authors.initials: JM
authors.lastname: Coindre
authors.forename: Serge
authors.initials: S
authors.lastname: Evrard
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D051677:Histiocytoma, Malignant Fibrous / Q000175:diagnosis* / Q000556:secondary / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D008175:Lung Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D018714:Radiotherapy, Adjuvant